Information Technology Services
Compare Stocks
5 / 10Stock Comparison
NYAX vs IIIV vs PRTH vs CWAN vs ACMR
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Software - Infrastructure
Software - Application
Semiconductors
NYAX vs IIIV vs PRTH vs CWAN vs ACMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Information Technology Services | Software - Infrastructure | Software - Infrastructure | Software - Application | Semiconductors |
| Market Cap | $2.67B | $506M | $451M | $7.21B | $3.92B |
| Revenue (TTM) | $404M | $223M | $953M | $826M | $901M |
| Net Income (TTM) | $36M | $16M | $56M | $-48M | $94M |
| Gross Margin | 46.3% | 60.4% | 21.4% | 66.0% | 44.4% |
| Operating Margin | 9.7% | 0.8% | 14.8% | 1.4% | 12.1% |
| Forward P/E | 81.5x | 20.3x | 5.8x | 34.6x | 29.7x |
| Total Debt | $338M | $8M | $1.05B | $883M | $303M |
| Cash & Equiv. | $412M | $67M | $77M | $91M | $766M |
NYAX vs IIIV vs PRTH vs CWAN vs ACMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 22 | May 26 | Return |
|---|---|---|---|
| Nayax Ltd. (NYAX) | 100 | 305.9 | +205.9% |
| i3 Verticals, Inc. (IIIV) | 100 | 114.4 | +14.4% |
| Priority Technology… (PRTH) | 100 | 122.2 | +22.2% |
| Clearwater Analytic… (CWAN) | 100 | 144.7 | +44.7% |
| ACM Research, Inc. (ACMR) | 100 | 475.1 | +375.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NYAX vs IIIV vs PRTH vs CWAN vs ACMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NYAX is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 38.0%, EPS growth 7.4%, 3Y rev CAGR 35.7%
- Lower volatility, beta 0.71, current ratio 2.26x
- Beta 0.71, current ratio 2.26x
- Beta 0.71 vs ACMR's 3.24
Among these 5 stocks, IIIV doesn't own a clear edge in any measured category.
PRTH ranks third and is worth considering specifically for income & stability.
- Dividend streak 3 yrs, beta 2.12
- Lower P/E (5.8x vs 29.7x)
CWAN is the clearest fit if your priority is growth.
- 61.9% revenue growth vs IIIV's -7.3%
ACMR carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 30.7% 10Y total return vs NYAX's 158.9%
- 10.4% margin vs CWAN's -5.8%
- 0.2% yield; 3-year raise streak; the other 4 pay no meaningful dividend
- +195.6% vs IIIV's -13.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 61.9% revenue growth vs IIIV's -7.3% | |
| Value | Lower P/E (5.8x vs 29.7x) | |
| Quality / Margins | 10.4% margin vs CWAN's -5.8% | |
| Stability / Safety | Beta 0.71 vs ACMR's 3.24 | |
| Dividends | 0.2% yield; 3-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +195.6% vs IIIV's -13.8% | |
| Efficiency (ROA) | 5.3% ROA vs CWAN's -1.6%, ROIC 15.2% vs 1.1% |
NYAX vs IIIV vs PRTH vs CWAN vs ACMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NYAX vs IIIV vs PRTH vs CWAN vs ACMR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CWAN leads in 1 of 6 categories
PRTH leads 1 • NYAX leads 1 • ACMR leads 1 • IIIV leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CWAN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PRTH is the larger business by revenue, generating $953M annually — 4.3x IIIV's $223M. ACMR is the more profitable business, keeping 10.4% of every revenue dollar as net income compared to CWAN's -5.8%. On growth, CWAN holds the edge at +74.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $404M | $223M | $953M | $826M | $901M |
| EBITDAEarnings before interest/tax | $65M | $31M | $204M | $94M | $126M |
| Net IncomeAfter-tax profit | $36M | $16M | $56M | -$48M | $94M |
| Free Cash FlowCash after capex | $32M | $10M | $75M | $152M | -$69M |
| Gross MarginGross profit ÷ Revenue | +46.3% | +60.4% | +21.4% | +66.0% | +44.4% |
| Operating MarginEBIT ÷ Revenue | +9.7% | +0.8% | +14.8% | +1.4% | +12.1% |
| Net MarginNet income ÷ Revenue | +8.9% | +7.3% | +5.8% | -5.8% | +10.4% |
| FCF MarginFCF ÷ Revenue | +7.8% | +4.7% | +7.9% | +18.5% | -7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +37.0% | -14.6% | +8.8% | +74.4% | +9.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +7.0% | -78.0% | +3.1% | -137.9% | -76.1% |
Valuation Metrics
PRTH leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 8.1x trailing earnings, PRTH trades at a 89% valuation discount to NYAX's 70.9x P/E. On an enterprise value basis, PRTH's 6.9x EV/EBITDA is more attractive than CWAN's 70.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.7B | $506M | $451M | $7.2B | $3.9B |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $447M | $1.4B | $8.0B | $3.5B |
| Trailing P/EPrice ÷ TTM EPS | 70.93x | 40.91x | 8.10x | -173.50x | 43.21x |
| Forward P/EPrice ÷ next-FY EPS est. | 81.48x | 20.30x | 5.78x | 34.60x | 29.68x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.22x |
| EV / EBITDAEnterprise value multiple | 45.28x | 14.02x | 6.95x | 70.39x | 27.49x |
| Price / SalesMarket cap ÷ Revenue | 6.17x | 2.37x | 0.47x | 9.85x | 4.35x |
| Price / BookPrice ÷ Book value/share | 11.79x | 1.51x | — | 3.24x | 2.06x |
| Price / FCFMarket cap ÷ FCF | 37.75x | 134.87x | 6.01x | 43.85x | — |
Profitability & Efficiency
NYAX leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
NYAX delivers a 17.5% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-2 for CWAN. IIIV carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to NYAX's 1.46x. On the Piotroski fundamental quality scale (0–9), PRTH scores 6/9 vs ACMR's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +17.5% | +3.2% | — | -2.4% | +6.1% |
| ROA (TTM)Return on assets | +5.3% | +2.6% | +2.6% | -1.6% | +3.9% |
| ROICReturn on invested capital | +15.2% | +0.6% | +13.4% | +1.1% | +7.0% |
| ROCEReturn on capital employed | +7.5% | +0.7% | +16.0% | +1.4% | +6.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 6 | 2 | 2 |
| Debt / EquityFinancial leverage | 1.46x | 0.01x | — | 0.43x | 0.16x |
| Net DebtTotal debt minus cash | -$74M | -$59M | $969M | $792M | -$463M |
| Cash & Equiv.Liquid assets | $412M | $67M | $77M | $91M | $766M |
| Total DebtShort + long-term debt | $338M | $8M | $1.0B | $883M | $303M |
| Interest CoverageEBIT ÷ Interest expense | 3.22x | 5.21x | 1.51x | 0.07x | 20.44x |
Total Returns (Dividends Reinvested)
ACMR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NYAX five years ago would be worth $25,895 today (with dividends reinvested), compared to $7,236 for IIIV. Over the past 12 months, ACMR leads with a +195.6% total return vs IIIV's -13.8%. The 3-year compound annual growth rate (CAGR) favors ACMR at 80.5% vs IIIV's -0.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +39.3% | -9.3% | +3.6% | +0.7% | +31.9% |
| 1-Year ReturnPast 12 months | +73.9% | -13.8% | -10.4% | +6.1% | +195.6% |
| 3-Year ReturnCumulative with dividends | +290.7% | -2.5% | +50.5% | +65.7% | +487.9% |
| 5-Year ReturnCumulative with dividends | +158.9% | -27.6% | -15.9% | -4.3% | +133.4% |
| 10-Year ReturnCumulative with dividends | +158.9% | +24.9% | -43.8% | -4.3% | +3065.8% |
| CAGR (3Y)Annualised 3-year return | +57.5% | -0.8% | +14.6% | +18.3% | +80.5% |
Risk & Volatility
Evenly matched — NYAX and CWAN each lead in 1 of 2 comparable metrics.
Risk & Volatility
NYAX is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than ACMR's 3.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CWAN currently trades 96.9% from its 52-week high vs PRTH's 62.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.71x | 0.92x | 2.12x | 0.80x | 3.24x |
| 52-Week HighHighest price in past year | $74.83 | $33.97 | $8.89 | $25.07 | $71.65 |
| 52-Week LowLowest price in past year | $37.95 | $19.89 | $4.44 | $15.74 | $19.26 |
| % of 52W HighCurrent price vs 52-week peak | +96.7% | +67.4% | +62.0% | +96.9% | +82.6% |
| RSI (14)Momentum oscillator 0–100 | 74.3 | 47.8 | 53.4 | 69.9 | 60.7 |
| Avg Volume (50D)Average daily shares traded | 21K | 292K | 252K | 4.0M | 1.2M |
Analyst Outlook
Evenly matched — PRTH and ACMR each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NYAX as "Buy", IIIV as "Buy", PRTH as "Buy", CWAN as "Hold", ACMR as "Buy". Consensus price targets imply 99.6% upside for PRTH (target: $11) vs -33.7% for NYAX (target: $48). ACMR is the only dividend payer here at 0.19% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $48.00 | $29.00 | $11.00 | $24.96 | $40.00 |
| # AnalystsCovering analysts | 6 | 14 | 5 | 13 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.2% |
| Dividend StreakConsecutive years of raises | — | — | 3 | 1 | 3 |
| Dividend / ShareAnnual DPS | — | — | — | — | $0.11 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +7.4% | +2.3% | +0.3% | +0.2% |
CWAN leads in 1 of 6 categories (Income & Cash Flow). PRTH leads in 1 (Valuation Metrics). 2 tied.
NYAX vs IIIV vs PRTH vs CWAN vs ACMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NYAX or IIIV or PRTH or CWAN or ACMR a better buy right now?
For growth investors, Clearwater Analytics Holdings, Inc.
(CWAN) is the stronger pick with 61. 9% revenue growth year-over-year, versus -7. 3% for i3 Verticals, Inc. (IIIV). Priority Technology Holdings, Inc. (PRTH) offers the better valuation at 8. 1x trailing P/E (5. 8x forward), making it the more compelling value choice. Analysts rate Nayax Ltd. (NYAX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NYAX or IIIV or PRTH or CWAN or ACMR?
On trailing P/E, Priority Technology Holdings, Inc.
(PRTH) is the cheapest at 8. 1x versus Nayax Ltd. at 70. 9x. On forward P/E, Priority Technology Holdings, Inc. is actually cheaper at 5. 8x.
03Which is the better long-term investment — NYAX or IIIV or PRTH or CWAN or ACMR?
Over the past 5 years, Nayax Ltd.
(NYAX) delivered a total return of +158. 9%, compared to -27. 6% for i3 Verticals, Inc. (IIIV). Over 10 years, the gap is even starker: ACMR returned +30. 7% versus PRTH's -43. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NYAX or IIIV or PRTH or CWAN or ACMR?
By beta (market sensitivity over 5 years), Nayax Ltd.
(NYAX) is the lower-risk stock at 0. 71β versus ACM Research, Inc. 's 3. 24β — meaning ACMR is approximately 353% more volatile than NYAX relative to the S&P 500. On balance sheet safety, i3 Verticals, Inc. (IIIV) carries a lower debt/equity ratio of 1% versus 146% for Nayax Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — NYAX or IIIV or PRTH or CWAN or ACMR?
By revenue growth (latest reported year), Clearwater Analytics Holdings, Inc.
(CWAN) is pulling ahead at 61. 9% versus -7. 3% for i3 Verticals, Inc. (IIIV). On earnings-per-share growth, the picture is similar: Nayax Ltd. grew EPS 737. 5% year-over-year, compared to -108. 3% for Clearwater Analytics Holdings, Inc.. Over a 3-year CAGR, NYAX leads at 35. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NYAX or IIIV or PRTH or CWAN or ACMR?
ACM Research, Inc.
(ACMR) is the more profitable company, earning 10. 4% net margin versus -5. 3% for Clearwater Analytics Holdings, Inc. — meaning it keeps 10. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRTH leads at 14. 8% versus 1. 9% for IIIV. At the gross margin level — before operating expenses — CWAN leads at 67. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NYAX or IIIV or PRTH or CWAN or ACMR more undervalued right now?
On forward earnings alone, Priority Technology Holdings, Inc.
(PRTH) trades at 5. 8x forward P/E versus 81. 5x for Nayax Ltd. — 75. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRTH: 99. 6% to $11. 00.
08Which pays a better dividend — NYAX or IIIV or PRTH or CWAN or ACMR?
In this comparison, ACMR (0.
2% yield) pays a dividend. NYAX, IIIV, PRTH, CWAN do not pay a meaningful dividend and should not be held primarily for income.
09Is NYAX or IIIV or PRTH or CWAN or ACMR better for a retirement portfolio?
For long-horizon retirement investors, Nayax Ltd.
(NYAX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), +158. 9% 10Y return). Priority Technology Holdings, Inc. (PRTH) carries a higher beta of 2. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NYAX: +158. 9%, PRTH: -43. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NYAX and IIIV and PRTH and CWAN and ACMR?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NYAX is a small-cap high-growth stock; IIIV is a small-cap quality compounder stock; PRTH is a small-cap deep-value stock; CWAN is a small-cap high-growth stock; ACMR is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.